Thorne review: is it worth it?

What is Thorne and who makes it?

Thorne (legally Thorne HealthTech) is a US supplement manufacturer founded in 1984 by Al Czap, originally in Seattle, then Sandpoint, Idaho, and now headquartered in South Carolina. The company went public on Nasdaq in 2021 and was taken private again in late 2023 when private-equity firm L Catterton acquired it for roughly $680 million (Thorne press releases; SEC filings). It is not a longevity-only company — Thorne sells hundreds of SKUs across vitamins, minerals, amino acids, sleep, gut, and sport categories — but it has built a distinct "healthy aging" franchise that is the focus of this review.

Two things set Thorne apart from most supplement brands, and both are verifiable rather than marketing fluff:

• Manufacturing rigor. Thorne's facilities are NSF-registered, and the company makes dozens of products that are NSF Certified for Sport, meaning each certified lot is screened by an independent lab for 270+ substances banned by WADA and major sports leagues — relevant because supplement contamination with stimulants and steroids is a real, documented problem. Thorne has also stated its manufacturing meets the requirements of Australia's Therapeutic Goods Administration (TGA), one of the world's stricter pharmaceutical-grade regulators (note: the TGA licenses and audits manufacturers for GMP compliance — it does not issue consumer-facing letter "grades" to companies). These are meaningful third-party signals of manufacturing quality and label accuracy.
• Research partnerships. Thorne is the only supplement manufacturer that collaborates with Mayo Clinic on wellness research and content, and its Biological Age work involves systems-biology scientists Dr. Leroy Hood and Dr. Nathan Price.

A reasonable independent read: Thorne is genuinely above-average on quality control and transparency. That does not, by itself, mean its longevity ingredients work — quality and efficacy are separate questions, and this review keeps them separate.

How is Thorne's longevity approach supposed to work?

Thorne's longevity strategy rests on a few mainstream geroscience ideas. The headline one is NAD+ (nicotinamide adenine dinucleotide), a coenzyme present in every cell that is essential for mitochondrial energy production, DNA repair, and the activity of sirtuin "longevity" enzymes. NAD+ levels decline with age, and the hypothesis — still a hypothesis — is that restoring NAD+ may support cellular function and healthy aging.

Thorne's flagship longevity formulas (ResveraCel and NiaCel) use nicotinamide riboside (NR), a vitamin B3 form that the body converts into NAD+. Around it, ResveraCel adds compounds meant to support related pathways: trans-resveratrol and quercetin (proposed sirtuin/AMPK modulators) and betaine (a methyl donor, included because NAD+ metabolism consumes methyl groups). The Biological Age test sits on top of this: it's meant to quantify how "old" your body is biochemically so you can track whether your interventions are moving the needle.

The logic is internally coherent. The open question — addressed below — is how much of it has actually been demonstrated in humans, versus mice and petri dishes.

What's in ResveraCel, and what does the evidence say for each ingredient?

ResveraCel is Thorne's signature healthy-aging capsule. Per 2-capsule serving it provides approximately:

• Nicotinamide riboside (as NR hydrogen malate / "NIAGEN"-type) — ~415 mg
• Quercetin phytosome — ~250 mg
• Trans-resveratrol — ~150 mg
• Betaine anhydrous — ~85 mg

Nicotinamide riboside (the strongest evidence here)

NR is the most clinically validated ingredient in the formula — but the validation is for *raising NAD+*, not for extending life. Multiple randomized, double-blind, placebo-controlled human trials show NR reliably and safely increases NAD+:

• In a 6-week crossover trial in healthy middle-aged and older adults, 1,000 mg/day of NR raised NAD+ in blood cells by ~60% versus placebo and was well tolerated (PMID 29599478). Blood pressure and arterial stiffness trended down but did not reach statistical significance after correction.
• In a trial of 120 adults aged 60–80, nicotinamide riboside combined with pterostilbene (NRPT) raised NAD+ by ~40% at the standard dose (sustained through 8 weeks); the double dose peaked at ~90% around 4 weeks and settled to roughly ~55% by 8 weeks, with no serious adverse events (PMID 29184669).

So: NR demonstrably does what it claims biochemically. Where evidence thins out is downstream clinical benefit. Trials testing harder endpoints have been mixed — for example, the NICE trial in peripheral artery disease found NR significantly improved 6-minute walk distance versus placebo (by ~17.6 m overall, larger among adherent participants), with resveratrol adding no benefit on top of NR (Nature Communications, 2024). By contrast, a randomized long-COVID trial raised NAD+ several-fold but missed its primary cognitive endpoint and showed no significant between-group benefit on fatigue, sleep, anxiety, or depression — essentially a null result with only exploratory within-group hints (Lancet eClinicalMedicine, 2025). Note also that ResveraCel's ~415 mg of NR per serving is *below* the 1,000 mg/day used in the strongest pharmacokinetic studies, so the NAD+ boost at label dose may be smaller than the headline trial numbers.

Resveratrol (popular, but the weakest link)

Resveratrol is famous from red-wine and "sirtuin activator" headlines, but human evidence for longevity is weak. Its core problem is poor oral bioavailability — it's rapidly metabolized, so blood levels stay low. More damaging to the original story: later work using better tools suggested resveratrol does *not* directly activate sirtuins as first claimed. Human trials report heterogeneous, often null effects on aging biomarkers, and no human trial has ever used lifespan as an endpoint. The 150 mg in ResveraCel is a reasonable dose, but the honest framing is "plausible antioxidant with disappointing human longevity data," not "proven."

Quercetin

Quercetin is a flavonoid with antioxidant and anti-inflammatory activity and is studied as a "senolytic" candidate (clearing senescent cells), usually paired with the drug dasatinib in research — not as a standalone supplement. Thorne uses a phytosome (lecithin-bound) form to improve absorption, which is a genuine bioavailability advantage over plain quercetin. Standalone human longevity evidence is preliminary.

Betaine

Betaine (trimethylglycine) is included on solid mechanistic grounds: NAD+ precursor metabolism consumes methyl groups, and betaine supports methylation. It's not a "longevity" ingredient on its own; it's a sensible supporting cofactor.

Does it actually work?

Here's the honest, two-part answer.

For surrogate biomarkers: yes, partially. NR clearly raises NAD+ in humans, and that's the closest thing the category has to a proven effect. If your goal is "increase my NAD+ levels," NR-based products like ResveraCel and NiaCel are a defensible, evidence-backed way to do it.

For the thing people actually want — living longer or aging slower: not demonstrated. No supplement, Thorne's included, has been shown in humans to extend lifespan or healthspan in a rigorous long-term trial. The entire field runs on surrogate endpoints (NAD+ levels, methylation clocks, lipid and inflammatory markers) because lifespan trials would take decades. Even the most credible pharmaceutical anti-aging effort — the metformin TAME trial designed to enroll ~3,000 older adults — remains only partially funded and unfinished, which tells you how immature the science is even on the prescription side. Anyone selling supplement-based "reverse your age" certainty is overselling the data, and to Thorne's credit its on-label language is generally more careful than many competitors'.

What is the Thorne Biological Age test, and is it worth it?

Thorne's Biological Age Health Panel (around $95) is a blood-based test — you order online and get a blood draw at a participating lab. It runs standard panels (comprehensive metabolic panel, lipids, complete blood count, plus inflammatory/metabolic markers) and feeds them into an algorithm that estimates your "biological age" plus organ-system sub-ages (liver, kidney, metabolic, lipid, blood). It was developed with systems-biology scientists Dr. Leroy Hood and Dr. Nathan Price.

Independent assessment:

• Pros: It's inexpensive, uses routine, well-validated biomarkers, and gives a digestible score plus actionable lifestyle/biomarker context. As a way to track trends over time and motivate behavior change, it's reasonable.
• Cons and caveats: A blood-biomarker "biological age" is fundamentally a clever repackaging of standard labs — much of the same information appears on a routine physical. It is *not* an epigenetic/DNA-methylation clock. Competitors like TruDiagnostic's TruAge (its flagship epigenetic test runs around $499; some tiers/subscriptions cost more) measure hundreds of thousands of CpG methylation sites (TruDiagnostic markets coverage on the order of ~900,000-plus loci), which is a different, more research-heavy approach (and more expensive). Neither type of test is a validated medical diagnostic, and "biological age" algorithms are not standardized across companies — your score depends heavily on which model is used. Treat any biological-age number as a rough, trackable estimate, not a verdict.

Who is Thorne longevity best for — and who should skip it?

Reasonable fit:

• People who specifically want to raise NAD+ and accept that the proven benefit is biochemical, not lifespan.
• Athletes and anyone who values NSF Certified for Sport / TGA-grade manufacturing and label accuracy.
• People who want a low-cost, repeatable lab-based score ($95 Biological Age panel) to track metabolic trends.

Should skip or pause:

• Anyone expecting proven anti-aging or "reverse my age" results — the evidence isn't there for any supplement.
• People who are pregnant, breastfeeding, or on prescription medications, especially blood thinners — resveratrol and quercetin can affect platelet function and drug-metabolizing CYP enzymes, creating real interaction potential. Check with a clinician first.
• Budget-conscious users who'd get more proven longevity value from cheaper basics (omega-3s, vitamin D if deficient, fiber, protein) and lifestyle factors — exercise, sleep, and not smoking remain the only interventions with strong human longevity evidence.

Side effects, safety, and interactions

NR has a clean safety record in trials — the main reported effects are mild and gastrointestinal (nausea, bloating). Quercetin is generally well tolerated; very high doses have been associated with kidney concerns and headache. Resveratrol can cause GI upset at higher doses and, more importantly, has antiplatelet activity and inhibits several CYP enzymes, so it can theoretically interact with anticoagulants (e.g., warfarin), antiplatelets, and drugs with narrow therapeutic windows. None of these ingredients is a substitute for medical care, and "supplement" status means the FDA does not review them for efficacy before sale (supplements are regulated as food, not drugs, under DSHEA). Thorne's third-party testing reduces the *contamination/label-accuracy* risk that plagues the category, but it does nothing to change inherent ingredient–drug interactions.

How to take it, cost, and value

ResveraCel's typical dose is 2 capsules daily; it can be taken with or without food, and many users take it in the morning given the energy-metabolism rationale. A bottle (60 capsules / ~30 servings) generally runs in the ~$50–$70 range, putting a month of ResveraCel plus a periodic $95 Biological Age panel at a real-but-not-extreme cost. On value: you're paying a premium over commodity NR for Thorne's verified quality control and clean formulation. That premium is defensible if certification matters to you; it is *not* buying you stronger longevity evidence than a cheaper, third-party-tested NR product would.

How does Thorne compare to alternatives?

• vs. Tru Niagen (ChromaDex): Tru Niagen is essentially pure NR (Niagen) and is the brand behind much of the NR research itself; it offers higher per-dose NR (often 300–1,000 mg) without the resveratrol/quercetin extras. If your only goal is NAD+, Tru Niagen is more focused; ResveraCel is a "stack" bet on multiple pathways.
• vs. Elysium Basis: Basis combines NR with pterostilbene (the molecule in PMID 29184669). Similar philosophy, different polyphenol.
• vs. epigenetic testing (TruDiagnostic): A different and pricier way to measure aging via DNA methylation rather than blood chemistry.
• vs. prescription approaches: Metformin and rapamycin are the most-discussed pharmaceutical longevity candidates, but neither is FDA-approved for aging and both require a prescription and monitoring. Supplements are easier to access but carry weaker evidence.

The bottom line

Thorne is one of the most credible brands in a category full of hype — its manufacturing, third-party certifications, and research partnerships are real differentiators, and its NR-based longevity products do the one thing they can prove: raise NAD+ safely. The hard truth, which applies to every brand and not just Thorne, is that no supplement has been shown to extend human life, resveratrol's longevity story is shaky, and "biological age" scores are useful trackers rather than diagnoses. If you want a high-quality NAD+ product and a low-cost lab panel to monitor trends — with realistic expectations and a check for drug interactions — Thorne is a sound choice. If you're chasing proven anti-aging, save your money for exercise, sleep, and the basics that actually have the evidence.